[The state of the colorectal screening in Hungary: lessons of the pilot programs].
In Hungary, colorectal cancer is the second most common malignant disease. Due to its natural history, colorectal cancer is particularly suitable for screening. At present, epidemiological evidences of the effectiveness of detection of the symptomless colorectal cancer and its precursors are only available for the demonstration of fecal occult blood, endoscopic methods are also in use. For mass screening, fecal occult blood tests are recommended. Guaiac-type chemical methods are widely criticized because of the lack of specificity. Out of the emerging technologies, immunochemical methods based on the antigenicity of blood proteins (hemoglobin) seem to be the most suitable. In the model programmes organized in the frame of the National Public Health Programme, an immunochemical method using two blood proteins (hemoglobin and albumin) have been used. The compliance was not more than 30-45%. About one-third of those with positive blood test refused colonoscopy. The programmes revealed a great number of adenomatous polyps and early cancers, and in the way, the effectiveness of the method has been proved. The model programmes are still continued. Before the continuous and gradual extension of colorectal screening, the validity of the specific method needs to be tested and proved in order to be recognized as a routine procedure for screening. There is a need to test the feasibility of total colonoscopy, however, to this effect the colonoscopic capacity in the country has to be further developed.
Döbrôssy
Lajos
L
Országos Tisztifoorvosi Hivatal Budapest. dobrossy@freemail.hu
Kovács
Attila
A
Budai
András
A
Cornides
Agnes
A
Ottó
Szabolcs
S
Tulassay
Zsolt
Z
D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D008403:Mass Screening / Q000379:methods; D009780:Occult Blood; D010865:Pilot Projects; D011237:Predictive Value of Tests; D011634:Public Health / Q000592:standards; D045808:Refusal to Participate; D012680:Sensitivity and Specificity